BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10460660)

  • 1. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression.
    Iczkowski KA; Shanks JH; Allsbrook WC; Lopez-Beltran A; Pantazis CG; Collins TR; Wetherington RW; Bostwick DG
    Histopathology; 1999 Aug; 35(2):150-6. PubMed ID: 10460660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of CD44 variant 6 expression differentiates small cell carcinoma of urinary bladder from urothelial (transitional cell) carcinoma.
    Iczkowski KA; Shanks JH; Bostwick DG
    Histopathology; 1998 Apr; 32(4):322-7. PubMed ID: 9602328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder.
    Buza N; Cohen PJ; Pei Hui ; Parkash V
    Int J Surg Pathol; 2010 Apr; 18(2):94-102. PubMed ID: 20164052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
    Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
    Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
    Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinosarcoma of the urinary bladder: a distinct variant characterized by small cell undifferentiated carcinoma with neuroendocrine features.
    Mazzucchelli L; Kraft R; Gerber H; Egger C; Studer UE; Zimmermann A
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(6):477-83. PubMed ID: 1281592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini.
    Chastain EC; Oliva IV; Osunkoya AO
    Pathology; 2012 Apr; 44(3):199-203. PubMed ID: 22406481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
    Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
    Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.
    McKenney JK; Desai S; Cohen C; Amin MB
    Am J Surg Pathol; 2001 Aug; 25(8):1074-8. PubMed ID: 11474293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
    Oliva E; Amin MB; Jimenez R; Young RH
    Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases.
    Lopez JI; Angulo JC; Flores N; Toledo JD
    Br J Urol; 1994 Jan; 73(1):43-9. PubMed ID: 7507782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract.
    Kim IE; Amin A; Wang LJ; Cheng L; Perrino CM
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):687-693. PubMed ID: 31876605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical profile of urothelial and small cell carcinomas of the bladder.
    Fernández-Aceñero MJ; Córdova S; Manzarbeitia F; Medina C
    Pathol Oncol Res; 2011 Sep; 17(3):519-23. PubMed ID: 21203907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult urinary bladder tumors with rhabdomyosarcomatous differentiation: clinical, pathological and immunohistochemical studies.
    Bing Z; Zhang PJ
    Diagn Pathol; 2011 Jul; 6():66. PubMed ID: 21762516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV.
    Bjerkehagen B; Fosså SD; Raabe N; Holm R; Nesland JM
    Eur Urol; 1994; 26(4):334-9. PubMed ID: 7713133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary small cell neuroendocrine carcinoma of the urinary bladder: a clinicopathologic, immunohistochemical, and ultrastructural evaluation.
    Hussein MR; Al-Assiri M; Eid RA; Musalam AO
    Ultrastruct Pathol; 2010 Aug; 34(4):232-5. PubMed ID: 20594044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
    Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
    Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing upper tract urothelial carcinoma diagnosis: Utility of cytokeratin 17 and CK20/CD44/p53 immunohistochemical panel.
    Irwin T; Donlan AW; Owens L; Alvarez R; Vakar-Lopez F; Tretiakova M
    Hum Pathol; 2024 Apr; 146():43-48. PubMed ID: 38593961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44v6 correlates with cell proliferation and cellular atypia in urothelial carcinoma cell lines 5637 and HT1197.
    Kuncová J; Kostrouch Z; Viale M; Revoltella R; Mandys V
    Folia Biol (Praha); 2005; 51(1):3-11. PubMed ID: 15783086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.